Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Validate the Safety and Feasibility of the CT-guided Interventional Robot in Percutaneous Lung Cryablation Procedures

NCT06581107 · Tianjin Medical University Cancer Institute and Hospital · Updated 3 Sept 2024

What is being tested
CT-fluoroscopy guided master-slave intervetional robot-assisted lung Cryoablation
For
Lung Cancer; Thoracic Cancer
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 75 years. About 20 people. The full rules are on the registry page.
Where
China
When
Starts or started 15 Sept 2024, ends 28 Feb 2025. Registered 3 Sept 2024.
Results
None posted yet.

In the researchers' words

This study aims to investigate whether the interventional robot can be well and safely used for percutaneous lung cryoablation in patients with lung cancer. The robot allows radiologists to remotely control the needle insertion process under CT fluoroscopy guidance. The main questions this study aims to answer are: 1. Whether the robot-assisted Cryoablation method can achieve complete the coverage of preoperatively planned ablation areas; 2. Whether the robot-assisted Cryoablation method can improve the success rate for radiologists to insert the needle into the target lesion area without additional needle adjustment; 3. Whether the robot-assisted Cryoablation method can reduce puncture time, ablation time and procedure time; 4. Whether the robot-assisted Cryoablation method can decrease the patient's complication occurrence rate; 5. Whether the robot-assisted Cryoablation method can obtain decent Evaluation of system performance.
ClinicalTrials.gov, NCT06581107

Sites

  • Tianjin Medical University, Cancer Institute & HospitalTianjin, Tianjin Municipality, China